Infor Cloverleaf partners with NVIDIA Holoscan to enhance clinical decision support through AI and deep learning, facilitating seamless healthcare dat...
Eli Lilly plans a significant $364 million investment in UK biotech growth and obesity research, aiming to fortify healthcare resource management and ...
The FDA will reevaluate its decision to bar compounders from making Eli Lilly's weight loss drugs, allowing temporary supply amid ingredient shortage ...
CVS Health is exiting its core infusion services, closing or selling 29 pharmacies, a strategic shift announced in a corporate memo. The move may resu...
Eli Lilly's obesity drug, Zepbound, is expected to gain approval in Japan by mid-2025. This comes amid growing global demand for obesity medications, ...
Microsoft Cloud for Healthcare introduces responsible AI solutions to enhance patient care, reduce healthcare costs, and alleviate workforce burnout w...